March 27, 2018 / 11:09 AM / 4 months ago

BRIEF-BioTime Announces Cash Sale Of Ascendance Biotechnology

March 27 (Reuters) - Biotime Inc:

* BIOTIME ANNOUNCES CASH SALE OF ASCENDANCE BIOTECHNOLOGY

* BIOTIME INC - BIOTIME SUBSIDIARY, AGEX, TO RECEIVE UP TO $3.5 MILLION IN CASH

* BIOTIME INC - AGEX RECEIVED APPROXIMATELY $3.2 MILLION UPON CLOSE OF ACQUISITION FOR ITS INTEREST IN ASCENDANCE

* BIOTIME - UPON TERMINATION OF ESCROW, AGEX WILL RECEIVE REMAINDER OF CONSIDERATION SUBJECT TO DEDUCTIONS OF LIABILITIES AND/OR EXPENSES FROM ESCROW Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below